Halozyme
HALO
HALO
121 hedge funds and large institutions have $810M invested in Halozyme in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
5% less funds holding
Funds holding: 128 → 121 (-7)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
Holders
121
Holding in Top 10
2
Calls
$13.2M
Puts
$10.5M
Top Buyers
| 1 | +$9.1M | |
| 2 | +$7.69M | |
| 3 | +$6.69M | |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$5.31M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.42M |
Top Sellers
| 1 | -$9.38M | |
| 2 | -$4.55M | |
| 3 | -$4.21M | |
| 4 |
Renaissance Technologies
New York
|
-$2.86M |
| 5 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$1.91M |